Cara Therapeutics, Inc. (CARA) Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845
Marijuana Stocks, Finance, & InvestingMedical Marijuana June 27, 2018
Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today announced positive top-line data from the adaptive Phase 2/3 trial of I.V. CR845 in patients undergoing abdominal surgeries. At the... Read more
The Green Organic Dutchman Holdings Ltd. (TGOD) (TGODF) ANNOUNCES CLOSING OF $25 MILLION SPECIAL WARRANT BOUGHT DEAL FINANCING
Marijuana Stocks, Finance, & Investing June 26, 2018
THE GREEN ORGANIC DUTCHMAN ANNOUNCES CLOSING OF $25 MILLION SPECIAL WARRANT BOUGHT DEAL FINANCING The Green Organic Dutchman Holdings Ltd. has closed its bought deal financing of 3.91 million special warrants of the company at $6.40 per special warrant for aggregate gross proceeds of approximately $25-million, previously announced on... Read more
